Kiio, Livongo, Mercer and Blue Cross Blue Shield Massachusetts speak candidly about how digital therapeutics are positively impacting health while averting lost productivity, disability, unnecessary medical costs and even opioid addiction
Boston, Mass (July 24, 2018) – Chronic conditions such as low back pain and diabetes are major drivers of medical and employment costs for employers and health plans. Kiio CEO David Grandin will be presenting at the Annual National Employee Health & Well Being Summit on how digital therapeutics are helping to treat these prevalent and costly medical concerns. For example, Kiio for Low Back Pain is shown to reduce pain, the reliance on opioids, and overall medical spending. Click here to read more about this upcoming panel and the latest news on digital therapies.